- Investing Ideas
- U.S. Pharmaceuticals & Biotech Nano Cap Stocks
U.S. Pharmaceuticals & Biotech Nano Cap Stocks
Results
19
Stocks with a market cap under US$50M.
19 companies
TScan Therapeutics
Market Cap: US$48.1m
A clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States.
TCRX
US$0.78
7D
5.2%
1Y
-54.9%
PDS Biotechnology
Market Cap: US$40.2m
A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States.
PDSB
US$0.73
7D
8.5%
1Y
-34.5%
Dyadic International
Market Cap: US$39.4m
A biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States.
DYAI
US$0.97
7D
-8.5%
1Y
-1.6%
Grace Therapeutics
Market Cap: US$35.5m
Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
GRCE
US$2.14
7D
2.9%
1Y
-27.9%
Bioqual
Market Cap: US$29.1m
Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.
BIOQ
US$32.50
7D
0%
1Y
n/a
BioXcel Therapeutics
Market Cap: US$26.6m
Together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.
BTAI
US$0.84
7D
4.8%
1Y
-74.7%
MariMed
Market Cap: US$25.5m
Engages in cultivation, production, and selling of branded cannabis products in the United States.
MRMD
US$0.063
7D
-6.8%
1Y
-42.0%
Actinium Pharmaceuticals
Market Cap: US$25.4m
Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.
ATNM
US$0.75
7D
-10.5%
1Y
-53.2%
TherapeuticsMD
Market Cap: US$23.6m
Operates as a pharmaceutical royalty company in the United States and internationally.
TXMD
US$2.07
7D
0.5%
1Y
87.3%
MDxHealth
Market Cap: US$22.3m
A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.
MDXH
US$0.43
7D
6.4%
1Y
-83.9%
Cellectar Biosciences
Market Cap: US$20.5m
A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.
CLRB
US$2.52
7D
1.6%
1Y
-47.3%
Jasper Therapeutics
Market Cap: US$18.6m
A clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States.
JSPR
US$0.66
7D
10.0%
1Y
-77.2%
Biofrontera
Market Cap: US$15.6m
A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
BFRI
US$1.24
7D
6.0%
1Y
21.6%
Bio Essence
Market Cap: US$13.5m
Engages in manufacturing and distributing health supplement products.
BIOE
US$0.25
7D
-7.5%
1Y
163.2%
Pharma-Bio Serv
Market Cap: US$9.7m
Operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.
PBSV
US$0.58
7D
37.3%
1Y
-3.3%
Traws Pharma
Market Cap: US$8.4m
A clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer.
TRAW
US$0.55
7D
15.0%
1Y
-63.6%
CordovaCann
Market Cap: US$5.4m
Engages in the provision of services and investment capital to the processing, production, and retail vertical markets of the cannabis industry in Canada and United States.
LVRL.F
US$0.04
7D
53.8%
1Y
-27.8%
Ayurcann Holdings
Market Cap: US$58.4k
Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.
AYUR.F
US$0.0003
7D
0%
1Y
-98.3%
Sunset Island Group
Market Cap: US$34.4k
Through its subsidiary, VBF Brands, grows, cultivates, manufactures, and distributes cannabis in the United States.
SIGO
US$0.0001
7D
0%
1Y
0%